🇺🇸 FDA
Pipeline program

Thymosin Alpha 1

TRACE trial

Approved small_molecule completed

Quick answer

Thymosin Alpha 1 for Pancreatitis, Acute Necrotizing is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Pancreatitis, Acute Necrotizing
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials